findmyKOL

Ambarish Pandey, MD

Enriched profile

Associate Professor, Department of Internal Medicine, Division of Cardiology · UT Southwestern Medical Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Dallas, TX · South Central · United StatesSpecialtyCardiovascular DiseaseFocusCardiovascular Function and Risk Factors+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2022–2025NIH funding2020–2026

Ambarish Pandey is Associate Professor, Department of Internal Medicine, Division of Cardiology at UT Southwestern Medical Center. OpenAlex indexes 647 publications with 35,834 citations (h-index 75); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 7 Sept 2026

Overview

Updated 14 Oct 2026

Ambarish Pandey, MD, is Associate Professor, Department of Internal Medicine, Division of Cardiology at UT Southwestern Medical Center, Dallas, Texas. The public record shows 647 publications with 35,834 citations (h-index 75), centered on Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, Cardiovascular and exercise physiology. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 25 companies, 7 NIH-funded awards (2020–2026).

  • Most recent indexed publication: 2026 · Nature medicine
  • Top research focus: Cardiovascular Function and Risk Factors
  • 9 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure6 trialsType 2 Diabetes1 trialCoronary Artery Disease / ACS1 trialCoronary Artery Disease1 trialAcute Coronary Syndrome1 trialHeart Failure, Systolic1 trialAtrial Fibrillation1 trialInflammation1 trial

Research focus

OpenAlex concept fingerprint
Cardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementCardiovascular and exercise physiologyDiabetes Treatment and ManagementCardiovascular Health and Risk Factors

Drugs & molecules

across trials, industry payments and publications
Steglatrogeneric · ErtugliflozinClinical trials—Industry payments11Publications2Furoscixgeneric · FurosemideClinical trials—Industry payments2Publications1Kerendiageneric · FinerenoneClinical trials—Industry payments28Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments8Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments3Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments1Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments1Publications—Nexlizetgeneric · Bempedoic acid / ezetimibeClinical trials—Industry payments1Publications—SotalolClinical trials—Industry payments1Publications—Tryviogeneric · AprocitentanClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials—Industry payments51Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments30Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments21Novo Nordisk IncClinical trials—Industry payments21Roche Diagnostics CorporationClinical trials—Industry payments16Pfizer Inc.Clinical trials—Industry payments12Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments11AstraZeneca Pharmaceuticals LPClinical trials—Industry payments11Roche Diagnostics International LtdClinical trials—Industry payments10Medtronic, Inc.Clinical trials—Industry payments9Novo Nordisk ASClinical trials—Industry payments8Abbott LaboratoriesClinical trials—Industry payments7University of Texas Southwestern Medical CenterClinical trials7Industry payments—Edwards Lifesciences CorporationClinical trials—Industry payments5Merck Sharp & Dohme LLCClinical trials—Industry payments5Scpharmaceuticals Inc.Clinical trials—Industry payments2Alleviant Medical, Inc.Clinical trials1Industry payments—AltaThera Pharmaceuticals LLCClinical trials—Industry payments1Anthos Therapeutics, Inc.Clinical trials1Industry payments—Anumana, Inc.Clinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Esperion Therapeutics, Inc.Clinical trials—Industry payments1Idorsia Pharmaceuticals Us IncClinical trials—Industry payments1Kilele Health IncClinical trials—Industry payments1Mindray DS USA, Inc.Clinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Roche Diabetes Care, Inc.Clinical trials—Industry payments1ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
647publications

Distinct works indexed by OpenAlex, matched via ORCID; 72 in PubMed.

35,834citations

Total citations across indexed works.

75h-index

Hirsch index (OpenAlex). i10-index 262.

Clinical & industry

trials, payments and federal funding
9clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
7NIH grants · 2020–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

25 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    65.1%
    Loop diuretic20.9%
    Torsemide51%Furosemide42%Furoscix7%
    Part D<11 patients
    Aldosterone antagonist (MRA)14.2%
    Spironolactone100%
    Part D≥50 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    34.9%
    SGLT2 inhibitor16.6%
    Jardiance85%Farxiga15%
    Part D<11 patients
    GLP-1 receptor agonist13.1%
    Ozempic70%Mounjaro20%Rybelsus10%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)52.5% facility · 47.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

7 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:

Congress activity

Updated 14 Oct 2026

5 congress contributions (2012–2022) across AACR, ADA, ASCO, ASH per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jarett D. Berry101Matthew W. Segar98Muthiah Vaduganathan98Colby Ayers97Gregg C. Fonarow82Kershaw V. Patel81James A. de Lemos78Neil Keshvani60Mark H. Drazner55Javed Butler50Robert J. Mentz50Dharam J. Kumbhani49Darren K. McGuire47Justin L. Grodin45Deepak L. Bhatt43Arman Qamar42Sandeep R. Das41Rohan Khera36Dalane W. Kitzman35Ian J. Neeland35W.H. Wilson Tang30Sameer Arora29Melissa C. Caughey28Alvin Chandra27Saket Girotra25Shreya Rao24Nilay Kumar23Sanjiv J. Shah21Marat Fudim21Clyde W. Yancy20Andrew Sumarsono20Vinayak Subramanian20Neetika Garg19Muhammad Shahzeb Khan19DuWayne L. Willett18Erin D. Michos18Michael E. Hall18Lin Zhong17Zainali Chunawala17Harsh Golwala17

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/ambarish-pandey-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/ambarish-pandey-17393314

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Ambarish-Pandey-38537375

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/RadcliffeCardiology/videos/%EF%B8%8Fnew-aha25-lbct-interview-dr-ambarish-pandey-joins-to-discuss-findings-from-the-/1770242800341504

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Instagram

    instagram.com/reel/DQ4dKWfElRV

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Instagram

    instagram.com/utswheartandvascular/p/DHoFRqmuVs2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Other

    hcplive.com/view/don-t-miss-a-beat-poly-hf-the-potential-of-polypills-in-hf-with-ambarish-pandey-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.S.C.S. (Master's in Clinical Science)

    UT Southwestern Graduate School of Biomedical Sciences

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • M.D.

    All India Institute of Medical Sciences, New Delhi

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Board Certified

    American Board of Internal Medicine - Cardiovascular Disease

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗

Editorial & leadership roles

journal and society appointments
  • Medical Director

    Heart Failure with Preserved Ejection Fraction (HFpEF) Program, UT Southwestern

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
  • Principal Investigator

    Cardiometabolic Research Unit (CMRU), UT Southwestern

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utsouthwestern.edu ↗
  • Associate Program Director

    Internal Medicine Residency Research, UT Southwestern

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.